Mitchell & Pahl Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,097
Closed -$206K 145
2025
Q3
$206K Sell
8,097
-299
-4% -$7.38K 0.09% 143
2025
Q2
$204K Sell
8,396
-393
-4% -$9.16K 0.09% 144
2025
Q1
$223K Sell
8,789
-105
-1% -$2.75K 0.1% 145
2024
Q4
$236K Sell
8,894
-4,839
-35% -$131K 0.11% 143
2024
Q3
$397K Sell
13,733
-2,489
-15% -$72.6K 0.19% 132
2024
Q2
$454K Sell
16,222
-94
-0.6% -$2.59K 0.24% 125
2024
Q1
$453K Sell
16,316
-1,994
-11% -$55.3K 0.24% 125
2023
Q4
$527K Sell
18,310
-2,616
-13% -$79.1K 0.3% 117
2023
Q3
$694K Sell
20,926
-617
-3% -$21.8K 0.41% 92
2023
Q2
$790K Sell
21,543
-723
-3% -$28.1K 0.48% 76
2023
Q1
$908K Sell
22,266
-1,546
-6% -$66.8K 0.57% 62
2022
Q4
$1.22M Sell
23,812
-533
-2% -$25.6K 0.8% 44
2022
Q3
$1.06M Sell
24,345
-1,425
-6% -$69.2K 0.79% 43
2022
Q2
$1.35M Sell
25,770
-2,069
-7% -$105K 0.94% 29
2022
Q1
$1.44M Sell
27,839
-1,121
-4% -$58.2K 0.92% 33
2021
Q4
$1.71M Buy
28,960
+726
+3% +$36K 1.1% 25
2021
Q3
$1.21M Sell
28,234
-137
-0.5% -$6.07K 0.87% 36
2021
Q2
$1.11M Sell
28,371
-156
-0.5% -$6.07K 0.79% 44
2021
Q1
$1.03M Sell
28,527
-600
-2% -$21.3K 0.8% 44
2020
Q4
$1.07M Buy
+29,127
New +$1.07M 0.9% 37

Other funds holding PFE

Mitchell & Pahl Private Wealth's PFE Position: Q4 2025 in Review

Mitchell & Pahl Private Wealth sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,097 shares — an estimated $206K sold.

Mitchell & Pahl Private Wealth first reported a position in PFE in Q4 2020 and held it in 20 quarters. The position peaked at $1.71M in Q4 2021. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Mitchell & Pahl Private Wealth reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Mitchell & Pahl Private Wealth sold 8,097 Pfizer shares in Q4 2025, an estimated $206K.
  • Mitchell & Pahl Private Wealth first reported a position in Pfizer in Q4 2020 and held it in 20 quarters.
  • Mitchell & Pahl Private Wealth's Pfizer position peaked at $1.71M in Q4 2021.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q4 2025, filed 14 Jan 2026.